Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated palifermin for reducing oral mucositis in locally advanced head and neck cancer patients undergoing postoperative radiotherapy with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Mucositis, Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-06